3.13
Oncology Institute Inc stock is traded at $3.13, with a volume of 1.76M.
It is down -2.49% in the last 24 hours and up +21.32% over the past month.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
See More
Previous Close:
$3.21
Open:
$3.21
24h Volume:
1.76M
Relative Volume:
0.88
Market Cap:
$309.37M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-3.962
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
-12.81%
1M Performance:
+21.32%
6M Performance:
-13.06%
1Y Performance:
+152.42%
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TOI
Oncology Institute Inc
|
3.13 | 309.37M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
485.72 | 108.59B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
199.63 | 17.36B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.03 | 12.31B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
202.92 | 11.79B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
185.92 | 11.36B | 17.36B | 1.51B | 849.25M | 23.15 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Needham | Buy |
| Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
| Jul-16-25 | Initiated | B. Riley Securities | Buy |
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI) - GuruFocus
Oncology Institute (NASDAQ:TOI) Major Shareholder Buys $83,750.00 in Stock - MarketBeat
Chernett Jorey buys Oncology Institute (TOI) shares worth $83,750 By Investing.com - Investing.com South Africa
Chernett Jorey buys Oncology Institute (TOI) shares worth $83,750 - Investing.com
Does The Oncology Institute Inc have strong fundamentals2026 Final Week & Short-Term High Return Strategies - baoquankhu1.vn
Major holder Chernett adds 25,000 Oncology Institute (NASDAQ: TOI) shares - Stock Titan
Breakout Zone: Will The Oncology Institute Inc outperform during market rallies2026 Growth vs Value & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Oncology Institute (TOI) director Kimberly Tzoumakas files initial Form 3 - Stock Titan
Oncology Institute (TOI) Earnings Transcript - AOL.com
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2025 Earnings Call Transcript - Insider Monkey
Oncology Institute Earnings Call Signals Profitable Shift - The Globe and Mail
Oncology Institute (TOI) CEO has shares sold to cover RSU taxes - Stock Titan
Oncology Institute (TOI) CFO reports RSU tax-related share sale - Stock Titan
Oncology Institute (TOI) CMO logs RSU tax-cover share sale on Form 4 - Stock Titan
Aug Catalysts: What is The Oncology Institute Inc Equity Warrants revenue forecast2026 Earnings Surprises & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Oncology Institute (NASDAQ:TOI) Major Shareholder Acquires $767,960.00 in Stock - MarketBeat
Insider Buying: Oncology Institute (NASDAQ:TOI) Major Shareholder Acquires 60,985 Shares of Stock - MarketBeat
Oncology Institute (NASDAQ:TOI) Major Shareholder Acquires $256,500.00 in Stock - MarketBeat
Chernett Jorey buys oncology institute (TOI) shares worth $1.2m By Investing.com - Investing.com India
Chernett Jorey buys oncology institute (TOI) shares worth $1.2m - Investing.com
Oncology Institute Insider Acquires Nearly 399K Shares - TradingView
Major holder boosts stake as Oncology Institute (TOI) insider buys shares - Stock Titan
The Oncology Institute: First Profitable Quarter & 2026 Outlook | 2025 ResultsNews and Statistics - IndexBox
New Highs: Whats the analyst consensus on The Oncology Institute IncGap Up & Safe Entry Zone Identification - baoquankhu1.vn
Insider Buying: Jorey Chernett Acquires Shares in The Oncology I - GuruFocus
Major TOI holder Jorey Chernett reports 9,852,944 Oncology Institute shares - Stock Titan
Chernett Amends 13G; Holds 10.23% of Oncology Institute (TOI) - Stock Titan
Oncology Institute Updates Investors With New Presentation - The Globe and Mail
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Sahm
B. Riley’s Price Target Boost Signals Growth for Oncology Institute - StocksToTrade
BTIG Remains a Buy on Oncology Institute (TOI) - The Globe and Mail
Oncology Institute (TOI) Q4 Loss Per Share Improvement Tests Longstanding Profitability Doubts - simplywall.st
The Oncology Institute (NASDAQ: TOI) furnishes updated investor presentation - Stock Titan
Oncology Institute (NASDAQ:TOI) Given New $8.00 Price Target at B. Riley Financial - MarketBeat
The Oncology Institute Reports Strong Q4 Results, Shares Surge - Intellectia AI
Oncology Institute’s Q4 Surprises Stir Investor Interest - StocksToTrade
The Oncology Institute, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
The Oncology Institute, Inc. (TOI) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ... By GuruFocus - Investing.com Canada
Oncology Institute Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Oncology Institute Q4 2025 beats EPS estimates, stock rises - Investing.com South Africa
The Oncology Institute: Value-Based Cancer Care Model, Growth Strategy, and Market Expansion Overview 32 - Minichart
Latest TOIIW NewsThe Oncology Institute Announces Promotion... - Stock Titan
Oncology Institute (NASDAQ:TOI) Issues Earnings Results - MarketBeat
Oncology Institute 2025 10-K: $502.7M Revenue, $(0.54) EPS - TradingView
The Oncology Institute (TOI) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 - The Manila Times
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance ... - Bluefield Daily Telegraph
The Oncology Institute, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Oncology Institute Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Analysts Are Bullish on Top Healthcare Stocks: Caribou Biosciences (CRBU), Oncology Institute (TOI) - The Globe and Mail
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):